Peter Boross

Utrecht, UT, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 33 publications

Editorial: Effector functions of therapeutic antibodies.

Editorial: Effector functions of therapeutic antibodies.

Journal: Frontiers in immunology

Published: December 18, 2022

Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity.

Preclinical anti-tumour activity of HexaBody-CD38, a next-generation CD38 antibody with superior complement-dependent cytotoxic activity.

Journal: EBioMedicine

Published: December 12, 2022

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models.

Mechanistic and pharmacodynamic studies of DuoBody-CD3x5T4 in preclinical tumor models.

Journal: Life science alliance

Published: April 13, 2022

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement.

Anti-PEG antibodies compromise the integrity of PEGylated lipid-based nanoparticles via complement.

Journal: Journal of controlled release : official journal of the Controlled Release Society

Published: June 11, 2021

Logic-gated antibody pairs that selectively act on cells co-expressing two antigens.

Logic-gated antibody pairs that selectively act on cells co-expressing two antigens.

Journal: Nature biotechnology

Published: March 30, 2021

Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy.

Anti-C2 Antibody ARGX-117 Inhibits Complement in a Disease Model for Multifocal Motor Neuropathy.

Journal: Neurology(R) neuroimmunology & neuroinflammation

Published: December 18, 2020

ARGX-117, a therapeutic complement inhibiting antibody targeting C2.

ARGX-117, a therapeutic complement inhibiting antibody targeting C2.

Journal: The Journal of allergy and clinical immunology

Published: February 27, 2020

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood.

Heparin Forms Polymers with Cell-free DNA Which Elongate Under Shear in Flowing Blood.

Journal: Scientific reports

Published: August 02, 2019

Sialic Acid-Engineered IL4-10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation.

Sialic Acid-Engineered IL4-10 Fusion Protein is Bioactive and Rapidly Cleared from the Circulation.

Journal: Pharmaceutical research

Published: June 17, 2019

New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies.

New insights in Type I and II CD20 antibody mechanisms-of-action with a panel of novel CD20 antibodies.

Journal: British journal of haematology

Published: September 15, 2017

Valley-enhanced fast relaxation of gate-controlled donor qubits in silicon.

Valley-enhanced fast relaxation of gate-controlled donor qubits in silicon.

Journal: Nanotechnology

Published: June 24, 2016

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting.

Improved in vivo anti-tumor effects of IgA-Her2 antibodies through half-life extension and serum exposure enhancement by FcRn targeting.

Journal: mAbs

Published: October 16, 2015

Showing 1-12 of 33

Last Updated: 09/26/2026